Advertisements


Hedge Funds Are Betting On Bristol Myers Squibb Co. (BMY)

A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual i.....»»

Category: topSource: insidermonkeyDec 7th, 2018

Hedge Funds Have Never Been This Bullish On Bristol Myers Squibb Company (BMY)

Russell 2000 ETF (IWM) lagged the larger S&P 500 ETF (SPY) by nearly 9 percentage points since the end of the third quarter of 2018.....»»

Category: topSource: insidermonkeyJun 5th, 2019

Is Bristol Myers Squibb Company (BMY) A Good Stock To Buy?

The government requires hedge funds and wealthy investors that crossed the $100 million equity holdings threshold are required to file a.....»»

Category: topSource: insidermonkeyMar 26th, 2019

Is Bristol Myers Squibb Co. (BMY) A Good Stock To Buy According To Hedge Funds?

A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual i.....»»

Category: topSource: insidermonkeyDec 8th, 2018

Sphera Funds Management Ltd. Buys Johnson & Johnson, Novo Nordisk A/S, Bristol-Myers Squibb ...

Related Stocks: BMY, ALXN, GILD, AZN, VRNT, GSK, JNJ, NVO, URGN, ICPT, NVS, A,.....»»

Category: personnelSource: nytJun 20th, 2019

Bristol-Myers says shareholders vote to approve Celgene takeover

Bristol-Myers Squibb Co's shareholders voted to approve the drugmaker's $74 billion takeover of biotech Celgene Corp on Friday despite a campaign by activist hedge fund Starboard Value LP to scuttle the deal......»»

Category: topSource: reutersApr 12th, 2019

Starboard no longer urging investors to vote against Bristol-Celgene deal

Activist hedge fund Starboard Value LP said on Friday it will no longer urge shareholders to oppose Bristol-Myers Squibb Co's plans to buy Celgene Corp, even though it thinks the deal is too risky and will vote its own shares against it......»»

Category: topSource: reutersMar 29th, 2019

Stada, buyout funds in race for Bristol-Myers" French business: sources

German generic drugmaker Stada is vying with a group of European buyout funds for control of Bristol-Myers Squibb's French over-the-counter drugs business, sources familiar with the matter told Reuters......»»

Category: topSource: reutersOct 8th, 2018

Starboard gauges Bristol-Myers shareholder support for Celgene deal

Activist hedge fund Starboard Value LP has asked a proxy solicitor to probe the level of support among Bristol-Myers Squibb Co shareholders for the U.S. drug maker's $74 billion deal to buy Celgene Corp, people familiar with the matter said on Friday......»»

Category: topSource: reutersFeb 15th, 2019

Bristol-Myers says Starboard nominated five directors, bought shares

Bristol-Myers Squibb Co. said on Wednesday that activist hedge fund Starboard Value LP wants to add five directors to its board and bought one million shares after the pharmaceutical company said it plans to buy biotech company Celgene Corp......»»

Category: topSource: reutersFeb 20th, 2019

Starboard to vote against Bristol-Myers-Celgene $74 billion deal

Activist investor Starboard Value LP will vote against Bristol-Myers Squibb Co's $74 billion acquisition of Celgene Corp, the hedge fund said on Thursday, adding to the number of shareholders declaring against the deal......»»

Category: topSource: reutersFeb 28th, 2019

Wellington Management Company To Vote Against BMY Merger

Celgene Corporation (CELG)’s stock falls after Wellington Management Company announced that it does not support Bristol-Myers Squibb Co (BMY)’s proposed acquisition. Q4 hedge.....»»

Category: blogSource: valuewalkFeb 28th, 2019

Legacy Capital Partners, Inc. Buys Broadridge Financial Solutions Inc, Bristol-Myers Squibb ...

Related Stocks: BMY, BIDU, BABA, AIZ, MIDD, FAST, BR, ANET, MDT, BDX, HRL, CT,.....»»

Category: personnelSource: nytJul 16th, 2019

Bristol-Myers Squibb Is Cheap

Bristol-Myers Squibb Is Cheap.....»»

Category: topSource: seekingalphaJul 3rd, 2019

Bristol-Myers Squibb Named Top Dividend Stock With Insider Buying and 3.62% Yield (BMY)

Dividend Channel.....»»

Category: topSource: redinewsJul 1st, 2019

Ex-Dividend Reminder: Bristol-Myers Squibb, Brixmor Property Group and Torchmark

Dividend Channel.....»»

Category: topSource: redinewsJul 1st, 2019

Stocks That Fell to 3-Year Lows in the Week of June 28

Bristol-Myers Squibb Company (BMY), UBS Group AG, Kellogg Co. and Molson Coors Brewing Co. have declined to their respective 3-year lowsRelated Stocks: BMY, UBS, K, TAP,.....»»

Category: blogSource: gurufocusJun 29th, 2019

Abbvie To Buy Allergan For $60 Billion In Latest Pharma Megadeal

Just months after Bristol-Myers Squibb and Celgene announced one of the biggest drug industry tie-ups in recent memory.....»»

Category: blogSource: zerohedgeJun 25th, 2019

Bristol-Myers Squibb Loses $6 Billion in Value on Celgene Deal Setback: Brainstorm Health

Bristol Myers surprised investors, announcing it would spin off Celgene's popular drug Otezla to address antitrust concerns. Happy Monday, readers! Bristol-Myers Squibb hasn’t exactly had a p.....»»

Category: europeSource: fortuneJun 24th, 2019

S&P says Bristol-Myers Squibb rating unchanged on Otezla sale

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 24th, 2019

Bristol-Myers Slips As Regulatory Hiccups Delay Celgene Deal; Liver Cancer Study Faces Setback

Uncertainty over Bristol-Myers Squibb Co (NYSE: BMY)'s impending deal to acquire Celgene Corporation (NASDAQ: CELG) and an adverse clinical trial readout were┬ádragging the shares of the large-cap pharma company lo read more.....»»

Category: blogSource: benzingaJun 24th, 2019